Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Ki-67 index value and progesterone receptor status can predict prognosis and suitable treatment in node-negative breast cancer patients with estrogen receptor-positive and HER2-negative tumors.

Arima N, Nishimura R, Osako T, Okumura Y, Nakano M, Fujisue M, Nishiyama Y, Toyozumi Y.

Oncol Lett. 2019 Jan;17(1):616-622. doi: 10.3892/ol.2018.9633. Epub 2018 Oct 29.

2.

Pertuzumab for the treatment of patients with human epidermal growth factor receptor 2-positive breast cancer in Japan.

Osako T, Nishimura R, Nishiyama Y, Fujisue M.

Mol Clin Oncol. 2015 Nov;3(6):1268-1274. Epub 2015 Sep 8.

3.

A Comparison of the Hot Spot and the Average Cancer Cell Counting Methods and the Optimal Cutoff Point of the Ki-67 Index for Luminal Type Breast Cancer.

Arima N, Nishimura R, Osako T, Nishiyama Y, Fujisue M, Okumura Y, Nakano M, Tashima R, Toyozumi Y.

Oncology. 2016;90(1):43-50. doi: 10.1159/000441525. Epub 2015 Nov 28.

PMID:
26613521
4.

The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index.

Arima N, Nishimura R, Osako T, Nishiyama Y, Fujisue M, Okumura Y, Nakano M, Tashima R, Toyozumi Y.

J Clin Pathol. 2016 Mar;69(3):255-9. doi: 10.1136/jclinpath-2015-203174. Epub 2015 Sep 29.

5.

Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study.

Tashima R, Nishimura R, Osako T, Nishiyama Y, Okumura Y, Nakano M, Fujisue M, Toyozumi Y, Arima N.

PLoS One. 2015 Jul 15;10(7):e0119565. doi: 10.1371/journal.pone.0119565. eCollection 2015.

6.

Survival time according to the year of recurrence and subtype in recurrent breast cancer.

Nakano M, Fujisue M, Tashima R, Okumura Y, Nishiyama Y, Ohsako T, Toyozumi Y, Arima N, Nishimura R.

Breast. 2015 Oct;24(5):588-93. doi: 10.1016/j.breast.2015.06.003. Epub 2015 Jun 20.

PMID:
26099804
7.

Prediction of sentinel lymph node status using single-photon emission computed tomography (SPECT)/computed tomography (CT) imaging of breast cancer.

Tomiguchi M, Yamamoto-Ibusuki M, Yamamoto Y, Fujisue M, Shiraishi S, Inao T, Murakami K, Honda Y, Yamashita Y, Iyama K, Iwase H.

Surg Today. 2016 Feb;46(2):214-23. doi: 10.1007/s00595-015-1160-0. Epub 2015 Apr 19.

PMID:
25893769
8.

Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer.

Osako T, Nishimura R, Nishiyama Y, Okumura Y, Tashima R, Nakano M, Fujisue M, Toyozumi Y, Arima N.

Int J Clin Oncol. 2015 Dec;20(6):1093-101. doi: 10.1007/s10147-015-0827-2. Epub 2015 Apr 9.

PMID:
25855313
9.

Prognostic significance of Ki-67 index value at the primary breast tumor in recurrent breast cancer.

Nishimura R, Osako T, Nishiyama Y, Tashima R, Nakano M, Fujisue M, Toyozumi Y, Arima N.

Mol Clin Oncol. 2014 Nov;2(6):1062-1068. Epub 2014 Aug 22.

10.

Evaluation of factors related to late recurrence--later than 10 years after the initial treatment--in primary breast cancer.

Nishimura R, Osako T, Nishiyama Y, Tashima R, Nakano M, Fujisue M, Toyozumi Y, Arima N.

Oncology. 2013;85(2):100-10. doi: 10.1159/000353099. Epub 2013 Jul 17.

11.

Clinical Significance of CK19 Negative Breast Cancer.

Fujisue M, Nishimura R, Okumura Y, Tashima R, Nishiyama Y, Osako T, Toyozumi Y, Arima N.

Cancers (Basel). 2012 Dec 21;5(1):1-11. doi: 10.3390/cancers5010001.

12.

Characterization of exo-(1,4)-alpha glucan lyase from red alga Gracilaria chorda. Activation, inactivation and the kinetic properties of the enzyme.

Yoshinaga K, Fujisue M, Abe J, Hanashiro I, Takeda Y, Muroya K, Hizukuri S.

Biochim Biophys Acta. 1999 Nov 16;1472(3):447-54.

PMID:
10564758
13.

Expression of periplasmic alpha-amylase of Xanthomonas campestris K-11151 in Escherichia coli and its action on maltose.

Abe J, Shibata Y, Fujisue M, Hizukuri S.

Microbiology. 1996 Jun;142 ( Pt 6):1505-12.

PMID:
8704990
15.

Establishment of tumor cell lines as an independent prognostic factor for survival time in patients with small-cell lung cancer.

Masuda N, Fukuoka M, Matsui K, Kusunoki Y, Kudoh S, Negoro S, Takifuji N, Fujisue M, Morino H, Nakagawa K, et al.

J Natl Cancer Inst. 1991 Dec 4;83(23):1743-8.

PMID:
1663169
16.

A cytoplasmic determinant for dorsal axis formation in an early embryo of Xenopus laevis.

Yuge M, Kobayakawa Y, Fujisue M, Yamana K.

Development. 1990 Dec;110(4):1051-6.

Supplemental Content

Loading ...
Support Center